4//SEC Filing
WATSON PHARMACEUTICALS INC 4
Accession 0001179110-08-009998
CIK 0000884629operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 6:22 PM ET
Size
8.3 KB
Accession
0001179110-08-009998
Insider Transaction Report
Form 4
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
- Sale
Common Stock, par value $0.0033
2008-05-15$28.65/sh−50,000$1,432,415→ 642,085 total(indirect: By Trust)
Holdings
- 89,428
Common Stock, par value $0.0033
- 40,000(indirect: By Trust)
Common Stock, par value $0.0033
Footnotes (3)
- [F1]Includes shares of restricted stock issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
- [F2]By Family Trust refers to the Hsia Family Trust, of which Dr. Hsia is a beneficial owner.
- [F3]By Partnership refers to the Hsia Interests, Ltd., of which Dr. Hsia is a general partner.
Documents
Issuer
WATSON PHARMACEUTICALS INC
CIK 0000884629
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0000884629
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 6:22 PM ET
- Size
- 8.3 KB